Dec 04, 2020 / 01:00PM GMT
Operator
Ladies and gentlemen, thank you for standing by and welcome to the Precision BioSciences Reports Positive Interim Results from PBCAR0191 Phase 1/2a Trial Conference Call.
At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question and answer session. (Operator Instructions) Please be advised that today's conference may be recorded. If you require any further assistance, please star zero.
I would now like to hand the conference over to your speaker today, Alex Kelly, please go ahead, sir.
Alex Kelly - Precision BioSciences - Chief Corporate Affairs Officer
Okay. Good morning everyone and welcome to our webcast to discuss the interim results for PBCAR0191 and relapsed and refractory NHL and BALL.
Before we begin, I would like to remind you that statements made during this webcast, that do not relate to matters of historical fact or like to future expectations in the lease, intentions goals, strategies, plans or prospects, our forward-looking statements within the meaning of the
Precision BioSciences Inc Interim Data Results for PBCAR0191- Conference Call Transcript
Dec 04, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers